Robotics improve discovery process
Drug discovery company De Novo Pharmaceuticals, of Cambridge, UK, is installing a PerkinElmer Life Sciences Mini-Trak and Multiprobe Robotics system with a clean air enclosure from Bigneat Containment Technology. This new robotics installation gives De Novo a high throughput drug testing capability in a safe working environment.
De Novo's in-house drug discovery programme involves the 'virtual' screening of molecules in silico to enable the selection of compounds likely to have pharmaceutical properties. The robotic system is being used alongside this process for in vitro testing.
